Corneal transplantation carries a high rate of success in the domestic cat and is an indicated treatment for specific corneal diseases in this species. The potential for iatrogenic transmission of viral diseases is a well-recognized problem in human corneal transplantation programs and screening donors for certain diseases is routine. Feline leukemia virus (FeLV) is a common agent of disease in domestic cats and available blood tests are highly effective in identification of infected individuals. This study investigates the presence of FeLV within corneal tissues of FeLV infected cats.
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Introduction
Corneal transplantation, more appropriately termed penetrating keratoplasty (PK), has become a successful clinical procedure used in human beings. This success follows over 150 years of failures due to a variety of complications. De Quengsy first introduced the concept of an artificial cornea in 1789 using glass similar to a watch crystal and substituting it for a scarred cornea, but there is no record of any actual attempt of this procedure in humans. 1 In 1796, Erasmus Darwin proposed the removal of a small portion of a clouded cornea with some sort of trephine and theorized the site would heal with a transparent scar. 2 Reisenger is credited with the concept that human corneal tissue could be replaced by corneal tissue from an animal, coining the term "keratoplasty" for the procedure. 3 Reisenger performed transplants in chickens and rabbits, although the success of these procedures is unknown.
The first successful corneal homograft was reported by Bigger in 1835, when he transplanted a clear cornea from one gazelle to another gazelle with a diseased cornea. 4
Not realizing the importance of using homologous tissue to his success, he suggested in the same publication that pig corneal tissue could be used to replace human corneal tissue. The first human corneal transplant procedure was performed in 1838, using a pig's cornea as donor tissue. 5 This attempt failed primarily due to sepsis and graft rejection because of use of heteroplastic material. Power, in 1872, declared that homoplastic material was necessary for successful corneal transplants and implied the corneal endothelium was also important to a successful outcome. 6 Von Hippel reported a successful heteroplastic lamellar graft in 1888 and described a circular trephine which he developed for use in this procedure. 7 A successful penetrating keratoplasty using homologous corneal tissue in a human was performed in 1905 when Dr. Eduard Zirm, using von Hippel's trephine, transplanted clear corneal buttons from an 11 year old boy to a man blinded by alkali corneal burns. Two of these were PK procedures and both were considered successful. PK has also shown promise as a therapy for primary corneal endothelial dystrophy. 13 Hacker reported successful results in both dogs and cats when frozen allograft tissue was used for tectonic grafting. 14 A recent case series describing PK for management of corneal stromal abscessation in horses suggests that it is a useful therapeutic modality for this disease. 15
Success rates for PK in the cat appear to be excellent. Experimental results with feline PK are on par with human beings with regard to a low incidence of rejection and resultant graft clarity. Following PCR, reaction products are separated by agarose gel electrophoresis.
Ethidium bromide can be incorporated in the gel or applied in a subsequent staining step to bind DNA which is present. This DNA-ethidium bromide complex will fluoresence under UV illumination allowing visualization of PCR products. If a DNA marker of known base pair (bp) size is included on the gel, it can be visually ascertained whether amplification of a sequence the size of the intended target has occurred. This is presumptive evidence that the DNA sequence in question was present in the original sample. Because there is a possibility of mispriming and production of products of a similar length, yet dissimilar sequence, confirmation of the identity of the reaction product is required. A common technique for confirming the identity of a nucleotide sequence involves use of a nucleotide probe which if present will hybridize to the sequence of interest. A more definitive method for determining identity of the reaction product is to evaluate its nucleotide sequence and compare this to the intended target. If sufficient homology exists between target and product nucleotide sequence, this confirms that the intended sequence was amplified. The objectives of this study were to determine the presence of FeLV proviral DNA and antigens in the corneal tissues of FeLV infected cats. PCR and immunohistochemical staining methods were employed. PCR was utilized due to the sensitivity and specificity of this technique, while immunoperoxidase staining was employed to provide localization of virus to particular regions of the cornea (i.e. epithelium, stroma, or endothelium).
Method and Materials
Thirty four random source cats of various ages and sexes were used in this study. n An initial denaturation step was performed at 95° C for 4 minutes. Each PCR cycle included denaturation at 95° C for one minute, primer annealing at 58° C for 1 minute and extension at 72° C for 1 minute. Thirty-five cycles were performed on each sample.
Samples were held at 4° C until further analysis. 
Cloning of PCR Product
Four randomly selected PCR positive samples were cloned for subsequent DNA sequencing using a commercial cloning kit. r A 2 µl sample of each PCR product to be cloned was inserted into a plasmid vector following the manufacturer's recommended protocol. The reaction was transformed into chemically competent E. coli cells From each culture plate, six white colonies were selected to screen for inserts.
Two dark blue colonies containing only plasmid vector were chosen as controls. A sample of each chosen colony was incubated in 1 ml Terrific Broth-Ampicillin (TB-Amp) media in a 1.6 ml microcentrifuge tube and also streaked on a TB-Amp master plate.
Both were incubated overnight at 37°C. Following incubation, liquid cultures were centrifuged at 10,000 rpm for 2 minutes. Supernatant was discarded and 5 µl RNAase was added to each tube. The cells were resuspended by vortexing and then allowed to incubate for 15 minutes. 50 µl phenol-chloroform was added to each tube and each sample was then vortexed for 1 minute. Samples were centrifuged at 15,000 rpm for 1 minute, and 10 µl of the supernatant was loaded onto a 1% agarose gel with ethidium bromide. Electrophoresis was performed at 100 volts for 1 hour and visualized under UV
transillumination. An approximately 500bp upward shift on the gel, when compared to the plasmid control, was interpreted to represent successful ligation of an insert. After determining which samples contained inserts, the growth on the corresponding master plate was cultured in 10 ml trypticase soy broth (TSB) t with 10 µl Ampicillin (200 µg/ml) added and incubated overnight at 37°C. Three milliliters from each culture tube was purified utilizing a commercial column per the manufacturer's recommended protocol.
u To verify that the correct PCR product had been inserted into the vector, restriction analysis was performed by digestion with EcoRI and 10µl of the product of this reaction was electrophoresed on a 1% agarose gel with ethidium bromide followed by visualization under UV transillumination.
DNA Sequencing and Analysis
DNA was purified for sequencing using a commercial DNA preparation kit following the manufacturers recommended protocol v and the product was resuspended in 35 µl sterile water. The purified DNA product was sequenced in both directions by a semi-automated fluorescent DNA sequencer w using the Cycle Sequencing Protocol.
Sequence analysis was performed. (Table 2) .
Discussion
Results of this study show that FeLV proviral DNA and FeLV antigens are present within the corneal epithelium of some FeLV infected cats. Immunohistochemical staining showed FeLV gp70 antigens to be localized to the anterior corneal epithelium.
Although FeLV has previously been detected in many epithelial tissues of infected cats, this is the first confirmation of corneal epithelial infection.
The majority of ELISA positive cats studied were also positive on peripheral blood IFA testing and were considered to be persistently infected with FeLV. IFA test results correlate well with VI studies, while VI attempts may be negative in some cats As the reagent controls and ELISA negative cornea samples were routinely negative on PCR testing, it is unlikely that cross contamination during PCR processing accounts for the higher detection rates with PCR.
It is of interest that no ELISA negative cats studied were positive on PCR or IHC tests. Random source cats might be expected to have a higher incidence of sequestered or latent infection with FeLV that might lead to negative ELISAs and positive PCR tests. PK is not performed frequently in the cat but indications for the procedure do exist and success rates for this procedure in this species are reported to be high. 16, 17 Because of the potential consequences of iatrogenic FeLV transmission, it is our recommendation that appropriate screening of corneal donors be performed. While ELISA positive animals had variable corneal PCR and IHC test results in this study, ELISA negative cats were consistently negative on PCR and IHC tests. This finding, in addition to previous documentation of the reliability of negative ELISA tests, suggests that a negative ELISA test is sufficient for excluding or decreasing the likelihood of iatrogenic FeLV transmission by PK. The presence of other feline retroviruses such as FIV in corneal tissues has not been reported, but testing donors for this virus would also be advisable. 
